歯周病治療市場の2030年までの予測： 製品タイプ、治療タイプ、薬剤、投与経路、流通チャネル、エンドユーザー、地域別の世界分析

Stratistics MRCによると、世界の歯周病治療市場は、2024年に9億861万米ドルを占め、予測期間中に11.2％のCAGRで成長し、2030年までに17億1,794万米ドルに達すると予想されています。

歯周病治療は、歯の周囲の組織や歯を支える組織に影響を及ぼす歯茎の感染によって引き起こされる損傷を管理し、回復させることに焦点を当てています。炎症や細菌を減少させるために、治療は通常スケーリングとルートプレーニングと呼ばれる専門的なクリーニングから始まります。さらに、感染を防ぎ回復を促すために、抗生物質や抗菌剤による治療が勧められることもあります。

米国国立歯科頭蓋顔面ラボ（NIDCR）によると、歯周病は成人の歯を失う主要原因であり、65歳以上の成人の70％近くが罹患しています。

歯周病有病率の増加

歯周病治療市場を促進する主要要因の1つは、これらの疾患の発生率が上昇していることです。米国疾病予防管理センター（CDC）によると、30歳以上の米国成人の47.2％が何らかの歯周病に罹患しています。この症状を持つ人の数は、人口の年齢とともに増加し、特に高齢者の間で増加しています。さらに、糖尿病、喫煙、口腔衛生習慣の不良など、特定の危険因子を持つ人は歯周病に罹患する可能性が高くなります。すべての年齢層において、歯周病の予防と治療に対する根強いニーズがあります。

高額な治療費

歯周病治療市場の主要抑制要因の1つは、特に歯科保険適用が制限されている地域における先進的治療費の高さです。骨移植、再生治療、先進的レーザー治療のような処置にかかる高額な費用は、多くの人々が治療を必要とするときに治療を受けることを躊躇させる可能性があります。歯周病の治療には数回の歯科受診が必要なことが多いため、出費はさらにかさみます。医療への支出が少なく、歯科保険が普及していないため、発展途上国ではこれらの治療を受けることはさらに困難です。

全身の健康管理との統合

歯の健康と全身の健康、特に糖尿病、心臓病、呼吸器疾患などの全身疾患との関連性が、人々の間で認識されるようになってきています。歯周病とこれらの健康問題を関連付ける調査が増えるにつれ、歯周治療をより包括的な医療管理に組み込む機会が増えています。このことは、歯科医師と医師が協力して、患者により包括的なケアを提供する機会を提供することになります。さらに、医療システムによっては、歯周病の治療が総合的な疾病管理計画に含まれる場合もあり、歯科医療従事者が他の医療従事者と協力する新たな機会が生まれています。

市販品との競合

歯周病治療市場にとって、歯周病の症状を軽減することを謳ったOTC製品は大きな脅威です。これらの商品には、フッ素入り歯磨き粉、抗菌マウスウォッシュ、電動歯ブラシやフロス器具のような様々な民生用電子機器が含まれます。さらに、これらの市販（OTC）製品は、専門家による治療ほど有効ではないかもしれないにもかかわらず、広く入手可能で、価格も手ごろであり、消費者向けに頻繁に大々的に販売されています。利便性，手頃な価格，あるいは自分の症状の深刻さについての知識不足のために，多くの患者は専門的な歯周治療を受けるよりも，これらの市販の代用品を使用することを決める可能性があります。

COVID-19の影響

歯周病治療市場は、COVID-19の大流行によって大きな影響を受けたが、その主要理由は、対面診療の禁止と、ロックダウン中の必要のない歯科処置の停止でした。多くの歯科医院が閉鎖を余儀なくされ、あるいは緊急治療が制限されたため、歯周病治療は延期されるか回避されました。医療機関でウイルスに感染することを恐れて、定期的な歯科診療の予約を延期したりキャンセルしたりする患者もいたため、専門的な歯周病治療の需要は減少しました。さらに、パンデミックの経済的不安の結果、患者の可処分所得が減少したため、緊急性のない歯科処置にお金を使う意欲が低下しました。

予測期間中、慢性歯周病セグメントが最大となる見込み

予測期間中、慢性歯周病セグメントが最大の市場シェアを占めると予想されます。歯の喪失を防ぎ、口腔の健康を回復するために、慢性歯周病は成人の間で一般的な疾患であり、通常、口腔衛生状態の悪化、喫煙、糖尿病、遺伝的素因などの要因によって引き起こされます。慢性歯周病は、特に高齢化社会に広く見られるため、歯科治療の大部分を占めています。さらに、慢性歯周病は歯肉の長期的な炎症と感染によって特徴付けられ、時間の経過とともに骨を含む歯を支える構造が徐々に破壊されていく。

予測期間中、CAGRが最も高くなると予想されるのは歯科クリニックセグメントです。

予測期間中、最も高い成長率を示すと予測されるのは歯科クリニックセグメントです。歯周治療に特化したクリニックの増加、口腔の健康に対する患者の意識の高まり、より個別化され、簡単に利用できる歯科治療への要望の高まりなどが、このセグメントの顕著な成長に寄与しています。先進的外科処置からスケーリング・ルートプレーニングのような非外科的方法まで、歯科クリニックは幅広い歯周病治療を提供しています。この市場は、審美歯科に対する需要の高まりに加え、サービスの利用しやすさと手頃な価格により拡大しています。さらに、より多くの患者が手頃な価格で実用的な治療法を求めているため、歯科クリニックは歯周病を管理する主要な場所となりつつあり、これが市場の爆発的な拡大に拍車をかけています。

最大シェアの地域

予測期間中、北米地域が最大の市場シェアを占めると予想されます。歯周病の罹患率の高さ、洗練された医療施設、口腔の健康に対する意識の高さが、この地域の優位性の主要要因です。外科的処置や再生処置などの先進的歯周病治療は、確立された歯科医療システムを誇る米国では広く利用可能です。また、同地域が市場で優位な地位を占めているのは、高い医療支出、大規模な高齢化、強固な歯科保険適用の結果でもあります。さらに、北米の歯周病治療における市場シェアは、歯科医療技術や製品における重要な参入企業の存在、継続的な研究開発によってさらに強化されています。

CAGRが最も高い地域

予測期間中、アジア太平洋が最も高いCAGRを示すと予測されます。都市化による歯周病罹患率の増加、食生活の変化、口腔衛生に対する意識の高まりなどが、この成長の要因の一部です。特に中国、インド、日本のような国々では、この地域の医療制度に大きな進歩が見られ、歯科治療へのアクセスが増加しています。急速な高齢化と可処分所得の増加も、歯周病治療の需要を押し上げています。さらに、アジア太平洋では、歯科クリニックや医療施設がより利用しやすく普及するにつれて、歯周病に対する先進的治療法の採用が大きく伸びると予想されます。

無料のカスタマイズ提供

本レポートをご購読の顧客には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

• 企業プロファイル
  • 追加市場参入企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推定・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携による主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• イントロダクション
• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の歯周病治療市場：製品別

• イントロダクション
• 装置
  • レーザー
  • 超音波スケーラー
  • 手術器具
• 消耗品
  • 歯科インプラント
  • 骨移植
  • 膜

第6章 世界の歯周病治療市場：疾患タイプ別

• イントロダクション
• 歯肉炎
• 慢性歯周病
• 進行性歯周病
• その他

第7章 世界の歯周病治療市場：治療タイプ別

• イントロダクション
• 非外科的治療
  • スケーリングとルートプレーニング
  • 抗生物質療法
• 外科的治療
  • 皮弁手術
  • 骨移植
  • 誘導組織再生

第8章 世界の歯周病治療市場：薬剤別

• イントロダクション
• 体系的抗生物質
• 局所抗生物質

第9章 世界の歯周病治療市場：投与経路別

• イントロダクション
• 経口
• 注射

第10章 世界の歯周病治療市場：流通チャネル別

• イントロダクション
• 病院薬局
• 小売薬局
• その他

第11章 世界の歯周病治療市場：エンドユーザー別

• イントロダクション
• 病院
• 歯科医院
• 歯科大学と研究機関
• その他

第12章 世界の歯周病治療市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他の欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他のアジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他の南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他の中東・アフリカ

第13章 主要開発

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第14章 企業プロファイリング

• 3M Company
• Keystone Dental Inc.
• DentalEZ, Inc.
• Envista Holdings Corporation
• Bego GmbH & Co. KG
• Millennium Dental Technologies, Inc.
• Straumann Group
• Geistlich Pharma AG
• Brasseler USA
• Nova Instruments
• A-Dec Inc.
• Parkell, Inc.
• Bausch Health Companies Inc.
• Yoshida Dental MFG. Co., Ltd.
• PreXion, Inc.

List of Tables

• Table 1 Global Periodontal Disease Treatment Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global Periodontal Disease Treatment Market Outlook, By Product (2022-2030) ($MN)
• Table 3 Global Periodontal Disease Treatment Market Outlook, By Equipment (2022-2030) ($MN)
• Table 4 Global Periodontal Disease Treatment Market Outlook, By Lasers (2022-2030) ($MN)
• Table 5 Global Periodontal Disease Treatment Market Outlook, By Ultrasonic Scalers (2022-2030) ($MN)
• Table 6 Global Periodontal Disease Treatment Market Outlook, By Surgical Instruments (2022-2030) ($MN)
• Table 7 Global Periodontal Disease Treatment Market Outlook, By Consumables (2022-2030) ($MN)
• Table 8 Global Periodontal Disease Treatment Market Outlook, By Dental Implants (2022-2030) ($MN)
• Table 9 Global Periodontal Disease Treatment Market Outlook, By Bone Grafts (2022-2030) ($MN)
• Table 10 Global Periodontal Disease Treatment Market Outlook, By Membranes (2022-2030) ($MN)
• Table 11 Global Periodontal Disease Treatment Market Outlook, By Disease Type (2022-2030) ($MN)
• Table 12 Global Periodontal Disease Treatment Market Outlook, By Gingivitis (2022-2030) ($MN)
• Table 13 Global Periodontal Disease Treatment Market Outlook, By Chronic Periodontal Disease (2022-2030) ($MN)
• Table 14 Global Periodontal Disease Treatment Market Outlook, By Aggressive Periodontal Disease (2022-2030) ($MN)
• Table 15 Global Periodontal Disease Treatment Market Outlook, By Other Disease Types (2022-2030) ($MN)
• Table 16 Global Periodontal Disease Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
• Table 17 Global Periodontal Disease Treatment Market Outlook, By Non-surgical Treatments (2022-2030) ($MN)
• Table 18 Global Periodontal Disease Treatment Market Outlook, By Scaling and Root Planing (2022-2030) ($MN)
• Table 19 Global Periodontal Disease Treatment Market Outlook, By Antibiotic Therapy (2022-2030) ($MN)
• Table 20 Global Periodontal Disease Treatment Market Outlook, By Surgical Treatments (2022-2030) ($MN)
• Table 21 Global Periodontal Disease Treatment Market Outlook, By Flap Surgery (2022-2030) ($MN)
• Table 22 Global Periodontal Disease Treatment Market Outlook, By Bone Grafting (2022-2030) ($MN)
• Table 23 Global Periodontal Disease Treatment Market Outlook, By Guided Tissue Regeneration (2022-2030) ($MN)
• Table 24 Global Periodontal Disease Treatment Market Outlook, By Drug (2022-2030) ($MN)
• Table 25 Global Periodontal Disease Treatment Market Outlook, By Systematic Antibiotics (2022-2030) ($MN)
• Table 26 Global Periodontal Disease Treatment Market Outlook, By Local Antibiotics (2022-2030) ($MN)
• Table 27 Global Periodontal Disease Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
• Table 28 Global Periodontal Disease Treatment Market Outlook, By Oral (2022-2030) ($MN)
• Table 29 Global Periodontal Disease Treatment Market Outlook, By Injectable (2022-2030) ($MN)
• Table 30 Global Periodontal Disease Treatment Market Outlook, By Distribution Channel (2022-2030) ($MN)
• Table 31 Global Periodontal Disease Treatment Market Outlook, By Hospital Pharmacies (2022-2030) ($MN)
• Table 32 Global Periodontal Disease Treatment Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
• Table 33 Global Periodontal Disease Treatment Market Outlook, By Other Distribution Channels (2022-2030) ($MN)
• Table 34 Global Periodontal Disease Treatment Market Outlook, By End User (2022-2030) ($MN)
• Table 35 Global Periodontal Disease Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 36 Global Periodontal Disease Treatment Market Outlook, By Dental Clinic (2022-2030) ($MN)
• Table 37 Global Periodontal Disease Treatment Market Outlook, By Dental Academics and Research Institutes (2022-2030) ($MN)
• Table 38 Global Periodontal Disease Treatment Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

According to Stratistics MRC, the Global Periodontal Disease Treatment Market is accounted for $908.61 million in 2024 and is expected to reach $1717.94 million by 2030 growing at a CAGR of 11.2% during the forecast period. Periodontal disease treatment focuses on managing and reversing the damage caused by gum infections that affect the tissues surrounding and supporting the teeth. In order to lower inflammation and bacteria, the treatment usually starts with a professional cleaning called scaling and root planing, which involves removing plaque and tartar from the teeth and under the gum line. Moreover, antibiotics or antimicrobial therapies may also be recommended to prevent infection and encourage recovery.

According to the National Institute of Dental and Craniofacial Research (NIDCR), periodontal disease is a leading cause of tooth loss in adults, affecting nearly 70% of adults aged 65 years and older.

Market Dynamics:

Driver:

Increasing periodontal disease prevalence

One of the key factors propelling the market for periodontal disease treatments is the rising incidence of these conditions. According to the Centers for Disease Control and Prevention (CDC), 47.2% of American adults over 30 suffer from some kind of periodontal disease. The number of people with this condition rises with population age, especially among older adults. Additionally, people with certain risk factors-such as diabetes, smoking, and poor oral hygiene habits-are more likely to suffer from periodontal diseases. Across all age groups, there is a persistent need for preventative and therapeutic treatments for periodontal disease due to the higher prevalence of these factors in the general population.

Restraint:

High expenses of treatment

One of the major restraints for the periodontal disease treatment market is the high cost of advanced treatments, especially in regions where dental insurance coverage is limited. The high cost of procedures like bone grafting, regenerative treatments, and advanced laser therapies may discourage many people from getting treatment when they need it. The expense is further increased by the fact that many treatments for periodontal disease necessitate several dental appointments. Due to lower healthcare spending and a lack of widespread dental insurance, these treatments are even more difficult to afford in developing nations.

Opportunity:

Integration with the management of systemic health

People are becoming more aware of the link between dental health and general health, especially when it comes to systemic diseases like diabetes, heart disease, and respiratory disorders. The opportunity to incorporate periodontal care with more comprehensive healthcare management is increasing as more research relates periodontal disease to these health problems. This offers dental practitioners and physicians the chance to work together to provide patients with more comprehensive care. Additionally, some healthcare systems may include treatment for periodontal disease in their overall disease management plans, opening up new opportunities for dental professionals to collaborate with other medical professionals.

Threat:

Rivalry from over-the-counter items

Over-the-counter (OTC) products that claim to manage or lessen the symptoms of gum disease pose a serious threat to the market for periodontal disease treatments. These goods include fluoridated toothpaste, antimicrobial mouthwashes, and a variety of household appliances like electric toothbrushes and flossing implements. Moreover, these over-the-counter (OTC) products are widely available, reasonably priced, and frequently heavily marketed to consumers, even though they might not be as effective as professional treatments. Due to convenience, affordability, or a lack of knowledge about the seriousness of their condition, many patients may decide to use these over-the-counter substitutes rather than seek professional periodontal care.

Covid-19 Impact:

The market for periodontal disease treatments was significantly impacted by the COVID-19 pandemic, mainly because of the prohibitions on in-person medical visits and the suspension of non-essential dental procedures during lockdowns. Due to the forced closure of many dental offices or the restriction of services to emergency care, periodontal treatments were either postponed or avoided. The demand for professional periodontal care decreased as a result of some patients delaying or canceling regular dental appointments out of fear of catching the virus in medical facilities. Additionally, patients were less willing to spend money on non-urgent dental procedures as a result of the pandemic's economic uncertainty, which decreased their disposable income.

The Chronic Periodontal Disease segment is expected to be the largest during the forecast period

The Chronic Periodontal Disease segment is expected to account for the largest market share during the forecast period. In order to prevent tooth loss and restore oral health, chronic periodontal disease is a common condition among adults and is usually caused by factors like poor oral hygiene, smoking, diabetes, and genetic predisposition. Because of its widespread occurrence, especially in aging populations, chronic periodontal disease accounts for a significant portion of dental treatments. Furthermore, chronic periodontal disease is characterized by long-term inflammation and infection of the gums, which over time causes the gradual destruction of the supporting structures of the teeth, including the bone.

The Dental Clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Dental Clinics segment is predicted to witness the highest growth rate. The growing number of specialized periodontal care clinics, increased patient awareness of oral health, and the growing desire for more individualized, easily accessible dental treatments are all contributing to this segment's notable growth. From sophisticated surgical procedures to non-surgical methods like scaling and root planing, dental clinics provide a broad range of periodontal treatments. This market is expanding due to the rising demand for aesthetic dentistry as well as better accessibility and affordability of services. Moreover, dental clinics are becoming the main location for managing periodontal disease as more patients look for affordable and practical treatment options, which are fueling their explosive market expansion.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. The high incidence of periodontal diseases, sophisticated healthcare facilities, and strong awareness of oral health are the main factors contributing to the region's dominance. Advanced periodontal treatments, such as surgical and regenerative procedures, are widely accessible in the United States, which boasts a well-established dental care system. The area's dominant position in the market is also a result of high healthcare spending, a sizable aging population, and robust dental insurance coverage. Furthermore, North America's market share in the treatment of periodontal disease is further reinforced by the existence of significant players in dental technologies and products as well as continuous research and development.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. The increasing incidence of periodontal diseases brought on by urbanization, dietary modifications, and growing awareness of oral health are some of the factors contributing to this growth. Significant advancements are being made in the region's healthcare system, especially in nations like China, India, and Japan, which are increasing access to dental care. A rapidly aging population and rising disposable incomes are also driving up demand for periodontal treatments. Moreover, the adoption of advanced treatments for periodontal disease is expected to grow significantly in the Asia-Pacific region as dental clinics and healthcare facilities become more accessible and widespread.

Key players in the market

Some of the key players in Periodontal Disease Treatment market include 3M Company, Keystone Dental Inc., DentalEZ, Inc., Envista Holdings Corporation, Bego GmbH & Co. KG, Millennium Dental Technologies, Inc., Straumann Group, Geistlich Pharma AG, Brasseler USA, Nova Instruments, A-Dec Inc., Parkell, Inc., Bausch Health Companies Inc., Yoshida Dental MFG. Co., Ltd. and PreXion, Inc.

Key Developments:

In November 2024, Geistlich Pharma AG announced an exclusive national distribution partnership agreement with StimLabs of Roswell, GA. StimLabs will assume all commercial activities for Geistlich's Advanced Wound Matrix effective immediately, offering a leading and clinically proven solution for acute and chronic wounds.

In November 2024, Nova announced that it has entered into a definitive agreement to acquire Sentronics Metrology GmbH, a privately held company headquartered in Mannheim Germany, in an all-cash transaction valued at approximately $60 million. The acquisition is subject to customary closing and regulatory conditions and approvals and is expected to close within the first quarter of 2025.

In August 2023, Keystone Dental Holdings, Inc. and Check-Cap Ltd. announced that they have entered into a definitive Business Combination Agreement under which the stockholders of Keystone Dental will become the majority holders of the combined company.

Products Covered:

• Equipment
• Consumables

Disease Types Covered:

• Gingivitis
• Chronic Periodontal Disease
• Aggressive Periodontal Disease
• Other Disease Types

Treatment Types Covered:

• Non-surgical Treatments
• Surgical Treatments

Drugs Covered:

• Systematic Antibiotics
• Local Antibiotics

Route of Administrations Covered:

• Oral
• Injectable

Distribution Channels Covered:

• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels

End Users Covered:

• Hospitals
• Dental Clinic
• Dental Academics and Research Institutes
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Periodontal Disease Treatment Market, By Product

• 5.1 Introduction
• 5.2 Equipment
  • 5.2.1 Lasers
  • 5.2.2 Ultrasonic Scalers
  • 5.2.3 Surgical Instruments
• 5.3 Consumables
  • 5.3.1 Dental Implants
  • 5.3.2 Bone Grafts
  • 5.3.3 Membranes

6 Global Periodontal Disease Treatment Market, By Disease Type

• 6.1 Introduction
• 6.2 Gingivitis
• 6.3 Chronic Periodontal Disease
• 6.4 Aggressive Periodontal Disease
• 6.5 Other Disease Types

7 Global Periodontal Disease Treatment Market, By Treatment Type

• 7.1 Introduction
• 7.2 Non-surgical Treatments
  • 7.2.1 Scaling and Root Planing
  • 7.2.2 Antibiotic Therapy
• 7.3 Surgical Treatments
  • 7.3.1 Flap Surgery
  • 7.3.2 Bone Grafting
  • 7.3.3 Guided Tissue Regeneration

8 Global Periodontal Disease Treatment Market, By Drug

• 8.1 Introduction
• 8.2 Systematic Antibiotics
• 8.3 Local Antibiotics

9 Global Periodontal Disease Treatment Market, By Route of Administration

• 9.1 Introduction
• 9.2 Oral
• 9.3 Injectable

10 Global Periodontal Disease Treatment Market, By Distribution Channel

• 10.1 Introduction
• 10.2 Hospital Pharmacies
• 10.3 Retail Pharmacies
• 10.4 Other Distribution Channels

11 Global Periodontal Disease Treatment Market, By End User

• 11.1 Introduction
• 11.2 Hospitals
• 11.3 Dental Clinic
• 11.4 Dental Academics and Research Institutes
• 11.5 Other End Users

12 Global Periodontal Disease Treatment Market, By Geography

• 12.1 Introduction
• 12.2 North America
  • 12.2.1 US
  • 12.2.2 Canada
  • 12.2.3 Mexico
• 12.3 Europe
  • 12.3.1 Germany
  • 12.3.2 UK
  • 12.3.3 Italy
  • 12.3.4 France
  • 12.3.5 Spain
  • 12.3.6 Rest of Europe
• 12.4 Asia Pacific
  • 12.4.1 Japan
  • 12.4.2 China
  • 12.4.3 India
  • 12.4.4 Australia
  • 12.4.5 New Zealand
  • 12.4.6 South Korea
  • 12.4.7 Rest of Asia Pacific
• 12.5 South America
  • 12.5.1 Argentina
  • 12.5.2 Brazil
  • 12.5.3 Chile
  • 12.5.4 Rest of South America
• 12.6 Middle East & Africa
  • 12.6.1 Saudi Arabia
  • 12.6.2 UAE
  • 12.6.3 Qatar
  • 12.6.4 South Africa
  • 12.6.5 Rest of Middle East & Africa

13 Key Developments

• 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 13.2 Acquisitions & Mergers
• 13.3 New Product Launch
• 13.4 Expansions
• 13.5 Other Key Strategies

14 Company Profiling

• 14.1 3M Company
• 14.2 Keystone Dental Inc.
• 14.3 DentalEZ, Inc.
• 14.4 Envista Holdings Corporation
• 14.5 Bego GmbH & Co. KG
• 14.6 Millennium Dental Technologies, Inc.
• 14.7 Straumann Group
• 14.8 Geistlich Pharma AG
• 14.9 Brasseler USA
• 14.10 Nova Instruments
• 14.11 A-Dec Inc.
• 14.12 Parkell, Inc.
• 14.13 Bausch Health Companies Inc.
• 14.14 Yoshida Dental MFG. Co., Ltd.
• 14.15 PreXion, Inc.